in subunit vaccine design for S protein of SARS-CoV-2 how can we lock its conformation into the premembrane-fusion state

Locking the conformation of the S protein of SARS-CoV-2 into the premembrane-fusion state is essential for subunit vaccine design as it allows the vaccine to elicit a strong immune response against the functional form of the protein. This can be achieved through various strategies, including the following:

1. Stabilizing mutations: Mutations can be introduced into the S protein to stabilize its conformation in the prefusion state. For example, the introduction of two proline residues (2P) at the S2' cleavage site has been shown to stabilize the prefusion conformation of the S protein, preventing its transition into the postfusion state.

2. Prefusion-stabilizing antibodies: Antibodies that specifically bind to and stabilize the prefusion conformation of the S protein can be used. These antibodies recognize and bind to specific epitopes on the S protein, preventing its conformational changes. These antibodies can be isolated from individuals who have recovered from COVID-19 or generated through immunization strategies.

3. Fusion inhibitors: Small molecules or peptides that inhibit the fusion process can be used to stabilize the prefusion conformation. These inhibitors bind to specific regions of the S protein involved in the fusion process, preventing its transition into the postfusion state.

4. Nanoparticle presentation: The S protein can be displayed on the surface of nanoparticles, such as virus-like particles (VLPs) or liposomes, which can stabilize the prefusion conformation. The nanoparticle provides a scaffold that mimics the viral surface, allowing the S protein to maintain its native conformation.

By employing these strategies, the conformation of the S protein can be locked into the prefusion state, ensuring that the subunit vaccine elicits an immune response against the functional form of the protein, leading to effective neutralization of the virus.